Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

For big data, big questions remain.

Fallik D.

Health Aff (Millwood). 2014 Jul;33(7):1111-4. doi: 10.1377/hlthaff.2014.0522. No abstract available.

PMID:
25006135
2.

FOLFIRI.3, a new regimen combining 5-fluorouracil, folinic acid and irinotecan, for advanced pancreatic cancer: results of an Association des Gastro-Enterologues Oncologues (Gastroenterologist Oncologist Association) multicenter phase II study.

Taïeb J, Lecomte T, Aparicio T, Asnacios A, Mansourbakht T, Artru P, Fallik D, Spano JP, Landi B, Lledo G, Desrame J.

Ann Oncol. 2007 Mar;18(3):498-503. Epub 2006 Dec 8.

PMID:
17158774
3.

Recurring acute abdominal pains in an adolescent as the presenting manifestations of hereditary angioneurotic oedema.

Foix-L'Hélias L, Weiss L, Mollet-Boudjemline A, Fallik D, Trioche-Eberschweiler P, Labrune P.

Acta Paediatr. 2005 Aug;94(8):1158-61.

PMID:
16188868
4.

Balance between pro and anti-inflammatory cytokines in patients with acute alcoholic hepatitis.

Naveau S, Balian A, Capron F, Raynard B, Fallik D, Agostini H, Grangeot-Keros L, Portier A, Galanaud P, Chaput JC, Emilie D.

Gastroenterol Clin Biol. 2005 Mar;29(3):269-74.

5.

Mesenteric adenitis and portal vein thrombosis due to Fusobacterium nucleatum.

El Braks R, Harnois F, Boutros N, Fallik D, Roudie J, Smadja C, De Laveaucoupet J, Chaput JC, Naveau S, Mathurin P.

Eur J Gastroenterol Hepatol. 2004 Oct;16(10):1063-6. Review.

PMID:
15371934
6.

Microsatellite instability is a predictive factor of the tumor response to irinotecan in patients with advanced colorectal cancer.

Fallik D, Borrini F, Boige V, Viguier J, Jacob S, Miquel C, Sabourin JC, Ducreux M, Praz F.

Cancer Res. 2003 Sep 15;63(18):5738-44.

7.

Hepatic arterial infusion using pirarubicin combined with systemic chemotherapy: a phase II study in patients with nonresectable liver metastases from colorectal cancer.

Fallik D, Ychou M, Jacob J, Colin P, Seitz JF, Baulieux J, Adenis A, Douillard JY, Couzigou P, Mahjoubi R, Ducreux M, Mahjoubi M, Rougier P.

Ann Oncol. 2003 Jun;14(6):856-63.

PMID:
12796022
8.

Meta-analysis: evaluation of adjuvant therapy after curative liver resection for hepatocellular carcinoma.

Mathurin P, Raynard B, Dharancy S, Kirzin S, Fallik D, Pruvot FR, Roumilhac D, Canva V, Paris JC, Chaput JC, Naveau S.

Aliment Pharmacol Ther. 2003 May 15;17(10):1247-61. Review.

9.

Risk factors of fibrosis in alcohol-induced liver disease.

Raynard B, Balian A, Fallik D, Capron F, Bedossa P, Chaput JC, Naveau S.

Hepatology. 2002 Mar;35(3):635-8.

PMID:
11870378
11.

[Small intestine bacterial overgrowth: six case reports and literature review].

Karsenti D, Bechade D, Fallik D, Bili H, Desrame J, Coutant G, Algayres JP, Daly JP.

Rev Med Interne. 2001 Jan;22(1):20-9. French.

PMID:
11218295
12.

[Response of metastatic colorectal cancers to treatment with CPT11 (irinotecan): implications of the mismatched base repair system].

Fallik D, Sabourin JC, Borrini F, Jacob S, Boige V, Praz F, Ducreux M.

Gastroenterol Clin Biol. 2000 Oct;24(10):917-22. French.

13.

[Iatrogenic dysphagia with severe consequences: simple preventive measures].

Karsenti D, Fallik D, Desrame J, Bili H, Coutand G, Algayres JP, Daly JP.

Presse Med. 1999 Feb 6;28(5):232. French. No abstract available.

PMID:
10076600

Supplemental Content

Loading ...
Support Center